Latest Breaking News On - Gilles gagnon - Page 1 : comparemela.com

Ceapro Inc Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc Reports Financial Results for First Quarter 2024 and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Gillesr gagnonGilles gagnonBeta glucanCeapro incExpanded technologyHealth canadaAeterna zentarisPipeline developmentMontreal heart instituteCorealis incManufacturing services corealisReports financial resultsFirst quarterProvides corporateData safety monitoring boardStability studies

Aeterna Zentaris : Audited Consolidated Financial Statements of Ceapro Inc as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 - Form 6-K

Aeterna Zentaris : Audited Consolidated Financial Statements of Ceapro Inc as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesStacy prefontaineUlrich kosciessaGilles gagnonRaymond chabot grant thorntonAeterna zentaris incCeapro incManagement of the companyUniversity of albertaNrdc incOffice equipmentAngiogenesis foundationAudit committeeShareholders of ceapro incInternational financial reporting standardsPublic company accounting oversight board united states

Ceapro Inc Reports 2023 Financial Results and Operational Highlights

– 2023 marked byCeapro’sachievement of key milestones and progress toward its next phase of growth

Beta glucanGillesr gagnonGilles gagnonProzesstechnologie gmbCorealis incMontreal heart instituteManufacturing services corealisCeapro incAvenanthramides malted technologyMcmaster universityAeterna zentarisAltasciences incUniversity of albertaMeeting of the wound healing societyHealth canadaData safety monitoring board

Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business

EDMONTON, Alberta, Feb. 23, 2024 Ceapro Inc. , today provided an update on its progress across its current business. On December 14, 2023, the Company announced it entered into a definitive.

United statesGillesr gagnonGilles gagnonJenene thomasBeta glucanAeterna zentarisExpanded technologyCosmeceutical base businessMontreal health institutePipeline developmentHealth canadaProduct developmentUniversity of albertaCeapro incCorporate communications advisorAeterna zentaris inc

Ceapro Inc Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

EDMONTON, Alberta, Feb. 15, 2024 Ceapro Inc. is pleased to announce that it has mailed and filed a management information circular dated February 9, 2024 and related meeting materials for.

Province of albertaUnited statesJenene thomasGilles gagnonAeterna zentarisAeterna zentariCompany the boardBroadridge investor communications corporationCompany theCompany the shareholdersExchange commissionAeterna zentaris incToronto stock exchangeData processing centreKing bench of alberta the courtCeapro inc